Activation of trigeminal nociceptors innervating the dural meninges likely underlies the headache phase of migraine (Weir and Cader, 2011), offering a plausible locus of action of the mutation due to the enrichment of TRESK in these afferents (Lafrenière et al., 2010). Here, KCNK18 is linked to migraine disorder.